To assess the possible role of ZEB1 in chemoresistance, we performed immunohistochemical staining for ZEB1 in 233 cases of human breast cancer treated with anthracyclines-based neoadjuvant chemotherapy. This evidence concerns the gene ZEB1 and breast cancer.